跳至主要内容
临床试验/NCT07304960
NCT07304960尚未招募不适用

Comparative Study Between Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder Patients in Assiut Hospitals Clinical and Laboratory Study

Assiut University0 个研究点目标入组 100 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
serum Glial Fibrillary Acidic Protein levels

研究概览

简要总结

The aim of this work is to do a detailed comparison between multiple sclerosis and Neuromyelitis Optica Spectrum Disorder due to delicate similarities between both diseases and wide rang of management and follow up of the patients

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 1- Both sex 2- Aged between 18 and 50 years. All included patients were in a clinically stable phase and had not experienced a relapse within at least three months before blood sampling. 3- All patients diagnosed as MS patients either naive or on disease modifying therapies according to The new diagnostic criteria MacDonalds 2024 4- DMT-naïve NMOSD patients: Diagnosed with MS based on the 2017 McDonald Criteria (Thompson et al., 2018)
  • 5- An informed consent will be obtained from all the patients; the study will be approved by ethical committee in faculty of Medicine Assiut University
  • 1_ Presence of other disorder that mimic MS or NMOSD 3_ Patients failed to commit to the follow up visits and regular MRI scans 4_ Patients refused to sign the written informed consent

排除标准

  • 1_ Presence of other disorder that mimic MS or NMOSD 3_ Patients failed to commit to the follow up visits and regular MRI scans 4_ Patients refused to sign the written informed consent

结局指标

主要结局

serum Glial Fibrillary Acidic Protein levels

时间窗: Baseline

Measurement of serum concentrations of Glial Fibrillary Acidic Protein at baseline using a validated immunoassay (e.g., single-molecule array \[Simoa\] assay). difference in serum Glial Fibrillary Acidic Protein levels between treatment-naïve NMOSD and treatment-naïve MS patientsexpressed in picograms per milliliter (pg/mL).

次要结局

  • Correlation between serum biomarkers (sGFAP and sNfL) and lesion burden on MRI.(Baseline)
  • Correlation between serum biomarkers (sGFAP and sNfL) and Expanded Disability Status Scale (EDSS).(Baseline)
  • Association between serum biomarkers and optic nerve involvement (length and presence of LETM).(Baseline)
  • Diagnostic performance of sGFAP and combined sGFAP + sNfL in differentiating NMOSD from MS.(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hussein Abd Elrahim Hussein Mohamed

Resident doctor

Assiut University

相似试验